Planning for financial impact of antiendotoxin monoclonal antibodies.
Bailey
G
G
Denman
J W
JW
Killilea
T
T
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D016527:Drug Costs; D005377:Financial Management, Hospital / Q000191:economics; D006780:Hospitals, Rural / Q000191:economics; D006801:Humans; D007075:Immunoglobulin M
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007075:Immunoglobulin M; C068069:nebacumab